Archives

The Carlyle Group Completes Purchase of StandardAero

Veritas Capital

Global investment firm The Carlyle Group (NASDAQ: CG) announced today that it has closed its purchase of StandardAero from Veritas Capital. StandardAero is a global provider of repair and maintenance services to the aviation industry.

“StandardAero has established itself as one of the true leaders in the MRO industry,” said Adam J. Palmer, Managing Director and Global Head of Aerospace, Defense and Government Services for The Carlyle Group. “We are excited to partner with the StandardAero team to continue supporting the Company’s growth and industry leadership.”

“Joining The Carlyle Group is a great honor and we look forward to working with this distinguished and experienced ownership team,” said Russell Ford, CEO of StandardAero.

Ramzi Musallam, CEO and Managing Partner of Veritas Capital said: “Veritas is pleased to have played an important role in StandardAero’s growth and success, and we believe the Company is well-positioned to continue its strong momentum. We thank Russ and the team for their successful partnership.”

StandardAero has more than 6,000 employees at 38 primary locations and dozens of field services and sales offices across five continents.

About StandardAero

StandardAero is one of the world’s largest independent providers of services including engine and airframe maintenance, repair and overhaul, engine component repair, engineering services, interior completions and paint applications. StandardAero serves a diverse array of customers in business and general aviation, airline, military, helicopter, components and energy markets. The company celebrated its 100th year of industry leadership in 2011. More information can be found on the company’s web site at www.standardaero.com.

About The Carlyle Group

The Carlyle Group (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across four business segments: Corporate Private Equity, Real Assets, Global Credit and Investment Solutions. With $216 billion of assets under management as of December 31, 2018, Carlyle’s purpose is to invest wisely and create value on behalf of our investors, portfolio companies and the communities in which we live and invest. The Carlyle Group employs more than 1,650 people in 31 offices across six continents.

Web: www.carlyle.com

Videos: www.youtube.com/onecarlyle

Tweets: www.twitter.com/onecarlyle

Podcasts: www.carlyle.com/about-carlyle/market-commentary

About Veritas Capital

Veritas Capital is a leading private equity firm that invests in companies that provide critical products and services, primarily technology and technology-enabled solutions, to government and commercial customers worldwide, including those operating in the aerospace & defense, healthcare, technology, national security, communications, energy, government services and education industries. Veritas seeks to create value by strategically transforming the companies in which it invests through organic and inorganic means. Veritas raised its first fund in 1998.  For more information on Veritas and its current and past investments, visit www.veritascapital.com.

Media Contact:

Kyle Hultquist

1.480.377.3192 – Office

1.602.577.2875 – Cell

kyle.hultquist@standardaero.com

Categories: News

Tags:

Teneo announces partnership with CVC

Investment will further expand and develop Teneo’s position as the world’s leading CEO advisory firm.

Teneo, the global CEO advisory firm, today announced it has reached an agreement with funds advised by CVC Capital Partners (“CVC”), a leading global private equity and investment advisory firm, to make an investment in the company.

The transaction, which is subject to regulatory approval and other customary closing conditions, will result in CVC Fund VII becoming the new private equity partner to Teneo, replacing BC Partners, which became an investor in the company in 2015. The terms of the new investment are not being disclosed.

Since the investment from BC Partners four-and-a-half-years ago, Teneo has more than tripled its global headcount to over 800 people and has also completed nine acquisitions, increasing its global presence to 19 offices in 12 countries.

The investment by CVC Fund VII will provide significant opportunity for the continued growth of Teneo’s operations through organic investment and acquisition focused across its four operating segments: Strategy & Communications; Management Consulting; Risk Advisory; and Capital Advisory.

“We are very pleased to welcome CVC as our new private equity partner,” said Declan Kelly, Chairman and CEO of Teneo. “The new partnership will enable us to further expand our operations around the globe to best serve the growing needs of our clients. I also want to thank the great team at BC Partners for their partnership and support of our business over the last several years.”

“CVC is excited to be entering a new partnership with Teneo,” said Christopher Stadler, Managing Partner at CVC. “We have been very impressed with the firm’s growth since it was founded in 2011 as well as its dedication to going above and beyond to deliver for its clients around the globe. We are very much looking forward to working closely with the management team to help execute their ambitious growth plans moving forward.”

“During our successful partnership, Teneo has nearly doubled EBITDA, both organically and through strategic acquisitions,” said Justin Bateman, Partner at BC Partners. “Since our initial investment in 2015, Teneo has executed nine acquisitions, which have been instrumental in expanding its geographic footprint, broadening its service offerings and continuing to build the company’s brand – positioning it as the leading global CEO and board advisory firm in the world.”

Categories: News

Tags:

Fortino Capital Partners invests in Maxxton, an all-in one ERP-software solution for the hospitality industry.

Fortino Capital

Fortino Capital Partners invests in Maxxton, an all-in one software solution developed for vacation & short-term rental managers. Maxxton, which employs 200 people, is headquartered in Middelburg, the Netherlands and has worldwide offices. Fortino Capital will assist the Maxxton management to further expand internationally and strengthen their current presence in vacation rentals, holidays parks and serviced apartments.

A unique software solution

Maxxton is a software as a service (SaaS) solution to simplify the reservation processes for hospitality managers. Its enterprise resource planning (ERP) platform caters specifically to the needs of the accommodation rental sector. Maxxton automates time-consuming manual work, increases efficiency and reduces staffing costs for hospitality organizations.

Jean-Pierre Mampaey, founder and CEO of Maxxton, initially developed the software for large chains like Roompot, a leading European holiday park operator. Jean-Pierre has a very strong expertise in the leisure industry and has since then taken Maxxton to clients worldwide. Maxxton addresses the complex needs of large vacation & short-term rental managers such as Roompot, Novasol and Castle Resorts.

Growth opportunities

The fragmented market of PMS (Property Management Software) offers attractive investment perspectives, driven by the favourable trends for the leisure industry in general, and the home rental and serviced apartments market in particular.

Historically, Maxxton gained a strong market position by addressing the complex needs of hospitality managers using the latest technologies.  Maxxton is currently rolling out a new version of its software with very positive feedback from its customers.

New majority stakeholder

As a majority shareholder, Fortino Capital will assist Maxxton to further expand internationally and to strengthen their presence in adjacent segments.

Matthias Vandepitte, Partner at Fortino Capital, explains: “We are delighted to support Maxxton with its ambitious growth strategy and we look forward to bringing our expertise in B2B software to Jean-Pierre and his team.”

Jean-Pierre Mampaey, founder of Maxxton, adds: “Over the last 2 decades, we have built a strong ERP software solution, initially for Roompot and today addressing the complex needs of clients all around the world. Together with Fortino Capital, we are now ready to bring Maxxton to the next level by strengthening our commercial organisation and broadening our product offering.”

Categories: News

Tags:

NEOMED-LABS / Pacific Biomarkers Strengthens its Immunology Franchise by Acquiring PAIRimmune

LAVAL, QC, June 6, 2019 – The recently merged NEOMED-LABS / Pacific Biomarkers (NLPBI), a leading immunology centric service provider specialized in assay development and clinical laboratory testing for vaccines and soluble large molecules, announced today the acquisition of PAIRimmune, a non-GLP preclinical immunology service provider based in Laval, Quebec.

With over 20 years of legacy in assay development, immunogenicity and efficacy predictive in vitro and in vivo models, PAIRimmune’s CEO Danielle Poirier and her team have a solid reputation for outstanding science within the community. Since 2015, they have been a CRO partner to small Biotech, academic groups and the most prestigious vaccine and large molecule Pharma companies.

“As a science-driven organization, nothing makes us happier than seeing talented scientists joining forces with us. This acquisition strengthens our ligand binding and neutralization assays R&D capabilities, and this is a determinant growth engine for each of our biomarkers, bioanalytical and vaccine divisions. PAIRimmune also increases our capacity and capabilities in flow cytometry and places us in a situation to answer positively to requests with either an in vivo, ex-vivo or immunohistology component. A perfect match!” said Dr Benoit Bouche, NLPBI President and Chief Executive Officer.

This acquisition reinforces NLPBI’s ability to serve the needs of the health industry from the preclinical stage where it is critical to develop robust data needed to make informed go/no-go decisions.

“The exponential growth of NLPBI these last years is impressive and proves the need for the emergence of a world class immunology specialist CRO. We are thrilled to become part of this story. Many of our employees are former GSK colleagues and old friends. Working in the same building in Laval gives us the feeling that we are already part of the family. Our clients will get access from day one to state-of-the-art labs and synergistic expertise that will result in an improved quality of service.”, said Danielle Poirier, President of PAIRimmune.

PAIRimmune will pursue its operations under the leadership of Danielle Poirier, Director of Preclinical Services and Matthieu Daugan, Associate Director of Preclinical Services.

PAIRimmune will be rebranded this fall at the same time as NEOMED-LABS and Pacific Biomarkers under a new corporate identity currently in development.

ABOUT NEOMED-LABS / Pacific Biomarkers

NEOMED-LABS / Pacific Biomarkers is a leading assay development and specialty clinical laboratory CRO whose versatile team of scientists and technology platforms were instrumental in the development, qualification, validation, and large-scale sample testing of assays that supported the FDA filing of almost 100 new molecular entities, including blockbuster vaccines and soluble large molecules. We proudly provide superior services and unrivaled expertise in immunology based on a client-centric team approach and expedited development time.

For more information, please visit: www.neomedlabs.com / www.pacbio.com

ABOUT PAIRimmune

PAIRimmune is a Contract Research Organization specialized in immunology evaluation for vaccine and immunotherapy development. We offer to our clients scientific methods combined with biopharma expertise to move forward early biological products. Based on in vivo and in vitro expertise, we build for our industry, academic and small biotech clients an adapted solution for their projects.

For more information, please visit: www.pairimmune.com

For more information, please contact:
Mounia Azzi
(514) 909-7714
mazzi@neomedlabs.com

Categories: News

Tags:

EURAZEO Capital and Sommet Education finalize the acquisition of Ducasse Education

Eurazeo

 

Paris, June 6,2019–Eurazeo capital is pleased to announce the acquisition of a 51% stake in Ducasse Education, a major player in culinary arts and pastry training, by the world-renowned hospitality management education group, Sommet Education.

Since its creation in 1999, Ducasse Education has developed and delivered un rivalled culinary and pastry expertise through a wide array of initial and professional development training programs, as well as courses for career changers. With three schools in France and international partnerships(the Philippines and soon the United Arab Emirates), the group boasts a multitude of innovative, methodological and technical expertise. Ducasse Education welcomes over 800 students and 3,000 apprentices at its three French campuses.

Sommet Education, a major higher education player, was built around Glion Institute of Higher Education and Les Roches Global Hospitality Education, two hospitality management institutions acquired by Eurazeo in 2016. With 5,000 students from over 100 countries, the group cultivates the global hospitality leaders of tomorrow. Located in Switzerland, Sommet Education is truly unique, as it is the only hospitality management group with two institutions ranked in the top four hospitality schools worldwide and the top three by employer reputation(QS World University Rankings by Subject 2019).

In line with its strategy to accompany the long-term development of its investments, Eurazeo Capital deploys all the financial, technical and human resources at its disposal to accelerate Sommet Education’s development and transformation. Since 2016, Eurazeo has notably helped to strengthen and internationalize the management team,while enabling the group to invest substantially in its campuses and tools to achieve its goal: create a global education leader in hospitality, gastronomy and services.

The acquisition of Ducasse Education demonstrates Sommet Education’s ability to combine premium educational brands. It will enable the group to propose more comprehensive and balanced training paths combining both long and short formats, and to expandfurther into professional development. Ducasse Education will benefit from Sommet Education’s structures, notably for the recruitment of new students, as well as Eurazeo’s expertise in international development, CSR and digitalization.

Marc Frappier,Head of Eurazeo Capital said: “With this investment decision and Eurazeo Capital’s support, Sommet Education will continue to develop, expanding its catalogue of training courses and becominga major player in hospitality and gastronomy education.”Benoit-Etienne Domenget, Chairman of Sommet Education, added: “This acquisition fits perfectly with our desire to strengthen our presence in the culinary arts, a sector which, we have noted, is of significant interest to the general public. We’re looking forward to working closely with the Ducasse Education teams and pooling our knowhow and expertise.”

MAITLAND/amoDAVID STURKENE-mail: dsturken@maitland.co.ukTel.: +44 (0) 7990 595 913For more information, please visit the Group’s website: www.eurazeo.comFollow us on Twitter,LinkedIn, andYouTube

PRESS CONTACT EURAZEO

CONTACTS

CAROLINE COHEN Head of Investor Relations ccohen@eurazeo.comTel.: +33 (0)1 44 15 16 76

VIRGINIE CHRISTNACHT Head of Communicationsvchristnacht@eurazeo.comTel.: +33 1 44 15 7644 ***

About Eurazeo

Eurazeo is a leading global investment company, with a diversified portfolio of €17 billion in assets under management, including nearly €11 billion from third parties, invested in over 300 companies. With its considerable private equity, real estate, private debt and fund of funds expertise, Eurazeo accompanies companies of all sizes, supporting their development through the commitment of its 235 professionals and by offering deep sector expertise, a gateway to global markets, and a responsible and stable foothold for transformational growth. Its solid institutional and family shareholder base, robust financial structure free of structural debt, and flexible investment horizon enable Eurazeo to support its companies over the long term.

Eurazeo has offices in Paris, New York, Sao Paulo, Buenos Aires, Shanghai, London, Luxembourg, Frankfurt and Madrid.

Eurazeo is listed on Euronext Paris.oISIN: FR0000121121 -Bloomberg: RF FP -Reuters: EURA.PA

About Sommet Education

Known for excellence in cultivating the hospitality leaders of tomorrow, Sommet Education encompasses a distinguished group of institutions united by a fundamental belief in the importance of academic rigor, skills-based learning and a dynamic multicultural outlook. Sommet Education institutions Glion and Les Roches serve students from more than 100 countries, preparing them to be immediately effective in their professions –wherever in the world these may be –while delivering exceptional consumer experiences.

Sommet Education is part of Eurazeo, one of the leading listed investment companies in Europe.

For more information,visitwww.sommet-education.com.

Categories: News

Tags:

Vitech to partner with CVC Capital Partners for next phase of growth

Global firm has over 1,200 professionals that serves many of the world’s leading pension, insurance and investment organisations.

Vitech Systems Group, a leading provider of cloud-based financial administration solutions, announced today that the firm has signed a definitive agreement with funds advised by CVC Capital Partners under which CVC Fund VII and CVC Growth Partners will make a majority investment in the New York-based technology firm.

Vitech is a global firm of over 1,200 professionals that serves many of the world’s leading pension, insurance and investment organisations. Vitech’s software, V3®, is available as a cloud-based solution via Vitech’s AWS-based V3locity™ platform.

Frank Vitiello, Vitech’s CEO, said, “This exciting partnership with CVC brings us the capital, market access, international reach and institutional expertise we need in order to maintain our current growth trajectory while we even more aggressively expand and advance our industry-leading offerings. CVC is a premier organisation and the investment in Vitech is a great validation of our success to date and of our future plans and prospects. I am excited by what this means for our software, our services, our clients and our employees.”

Chris Colpitts, Senior Managing Director at CVC said, “We have been impressed by Vitech’s offerings and success to date, and are excited to partner with Frank and his excellent management team in the next phase of growth.” Aaron Dupuis, Senior Managing Director at CVC Growth added, “Vitech’s strong growth and differentiated value proposition are an excellent fit with the CVC Growth Partners mandate. We are excited to partner with CVC Fund VII and management to capitalise on the significant market opportunity for Vitech.”

CVC Fund VII and CVC Growth Partners will jointly invest in Vitech. The existing management team will remain in place and will continue to run the firm with CVC’s backing and support.

Vitech was advised by RBC Capital Markets and Orrick, Herrington & Sutcliffe LLP, and assisted by Clearsight Advisors. CVC was advised by Citi, Goldman Sachs & Co. LLC and White & Case LLP. The investment is expected to close later this summer.

Categories: News

Tags:

Genstar Capital Announces Agreement to Acquire Advarra from Linden Capital Partners

Partnership with Management to Continue Growing Industry-Leading Compliance Business Focused on Increasing Safety and Efficiency in Clinical Trials

SAN FRANCISCO, June 6, 2019—Genstar Capital (“Genstar”), a leading private equity firm focused on investments in targeted segments of the healthcare, software, industrial technology, and financial services industries, announced today that it has recently signed a definitive agreement to acquire Advarra (“Advarra” or the “Company”), a leading provider of compliance solutions that are critical to the drug development process, from Linden Capital Partners (“Linden”), which intends to reinvest in the Company via a minority investment upon completion of the transaction.

Advarra is a leading provider of institutional review board (IRB), institutional biosafety committee (IBC) and research quality and compliance services, which are mandated by regulatory agencies for all trial protocols, patient forms, site initiations and trial modifications. The Company serves leading pharmaceutical, biotechnology, medical device and contract research organizations (CROs), as well as academic medical centers, hospital systems, investigative site networks, and therapeutic research consortia, and has relationships with over 3,200 institutional sites. Advarra is headquartered in Columbia, MD and was formed through the merger of Chesapeake IRB and Schulman IRB in 2017; in March 2019, the Company completed its acquisition of Quorum Review.

David Golde, Managing Director of Genstar, said, “Genstar has a long track record of building industry-leading businesses in the pharmaceutical services sector through our investments in CRF Bracket, ERT, and PRA Health Sciences, among others. We were extremely impressed with the market leading platform that Pat Donnelly and his team have built in the regulatory compliance segment of clinical trials. We are excited for Advarra to continue leveraging its leading reputation in the IRB and regulatory compliance industry, while expanding, both organically and through strategic acquisitions, into other ancillary services to better serve its customers.  Genstar looks forward to collaborating with Advarra’s management team to further its mission with all of the constituencies that depend upon safe and efficient progress of pharmaceutical research.”

Pat Donnelly, Chief Executive Officer of Advarra, said, “IRBs are required and critical to the drug development process and the increasing complexity of clinical trials and need to adhere to evolving and strict FDA guidelines will continue to drive the importance of our services. Advarra is devoted to enhancing the safety of clinical trial subjects around the world and to improving the efficiency of clinical trial execution for all stakeholders including sponsors, academic institutions, hospital systems, and CROs. This new partnership with Genstar augments our resources to further the important mission of our Company and to continue to unlock value for our customers. On behalf of the management team, we are grateful for Linden’s strong stewardship over the last several years.”

Tony Davis, President and Managing Partner at Linden, said, “We are proud to have played a role scaling Advarra into a truly differentiated platform as the industry-leading IRB, which is a result of our targeted value creation initiatives over the last three and a half years, most notably significantly investing in infrastructure and strategic acquisitions. The Company is very well positioned to continue on its growth trajectory, building on a long history of outperformance, superior human subject protection and leading therapeutic area specialization. We are excited about our intention to invest alongside Genstar and continue to support Advarra through its next phase of growth.”

Jefferies is serving as lead financial advisor and Houlihan Lokey is serving as co-financial advisor to Linden and Advarra. Kirkland & Ellis LLP is serving as legal counsel to Linden and Advarra in connection with this transaction. Ropes & Gray LLP is serving as legal counsel to Genstar.

About Advarra

Advarra, headquartered in Columbia, MD, provides institutional review board (IRB), institutional biosafety committee (IBC), and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers, and investigators. Its robust regulatory expertise and innovative technology ensure the highest standards of research review are met, while putting participants first and meeting complex human research protection oversight requirements. Advarra supports all phases of research across multiple therapeutic areas. Visit www.advarra.com.

About Genstar Capital

Genstar Capital (www.gencap.com) is a leading private equity firm that has been actively investing in high quality companies for over 30 years. Based in San Francisco, Genstar works in partnership with its management teams and its network of strategic advisors to transform its portfolio companies into industry-leading businesses. Genstar currently has approximately $17 billion of assets under management and targets investments focused on targeted segments of the healthcare, software, industrial technology, and financial services industries.

About Linden Capital Partners

Linden Capital Partners is a Chicago-based private equity firm focused exclusively on investing in the healthcare industry. Linden’s strategy is based upon three elements: i) healthcare specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden invests in middle market platforms across the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. For more information, please visit www.lindenllc.com.

###

MEDIA INQUIRIES:

Contact: Chris Tofalli
Chris Tofalli Public Relations
914-834-4334

Categories: News

Tags:

Medxoom Raises $3.2M Financing to Bring Transparency to Medical Billing

TTVcapital

Healthcare benefits platform Medxoom has raised a $3.2 million financing round led by Las Olas VC and TTV Capital. The “late seed” also saw participation from Lattice.VC and several healthcare and payments industry executives.

Medxoom’s CEO and co-founder Jeffrey Toewe shares that this was the right time to raise additional funds as they’ve recently secured several large deals and needed to grow the team to meet the demand.

“We’re looking forward to scaling our existing clients, securing new business and growing our team in Atlanta,” Toewe tells Hypepotamus. “[We] power a better experience for those seeking the best care providers for themselves and their loved ones. We look forward to driving meaningful improvements in America’s evolving healthcare space.”

Toewe and his co-founder Tito Milla decided to target the medical billing space after they had confusing personal experiences.

Patients rarely receive accurate estimates of medical procedures prior to an appointment. This makes it difficult to prepare financially, as the bill often depends on insurance coverage.

Medxoom’s healthcare marketplace app simplifies pricing for medical procedures. It is provided as a company benefit to employees, who receive access to the app via their HR team.

Since the app is already familiar with their employer’s healthcare plan, it displays an accurate price for procedures across a physician marketplace. This helps the employee make an informed decision based on their budget.

“Our mission is to put more of this information out in the sun and help consumers and employers know what these price benchmarks are,” Toewe told Hypepotamus last year.

“The Medxoom product suite empowers consumers with a financial decisioning tool for their healthcare spend, while expanding the coverage options for self-insured employers who have the opportunity to optimize their health benefits experience,” says Atlanta-based TTV Capital’s Sean Banks in a statement.

The Atlanta-based SaaS startup will grow its team to roughly 15 employees, says Toewe. They’ve onboarded more than 40 clients at this time.

Categories: News

Tags:

Tikehau Capital and Le Groupe de l’Hôtellerie acquire two hotels in Paris

Tikehau

Paris, 5June 2019– Tikehau Capital, the alternative asset management and investment group, with Le Groupe de l’Hôtellerie, the hotel management, investment and development specialist, acquire two hotels in central Paris through Tikehau Capital’s Real Estate value-added fund.

The Hotel Corona Opéra and the Hotel Touraine Opéra are both three star hotels with a combined capacity of 97 rooms. These hotelsare located in the historical 9thdistrict of Paris, close to the Paris Opera and the large department stores. Built during the 19th century, the hotels have strong potential for development while the hospitality and leisure sector in Paris is growing 1and offers many opportunities.

A third acquisition for Tikehau Capital’s Real Estate value-added fund

This operation is Tikehau Capital’s Real Estate Value-Added fund third acquisition following its partnership with Bouygues Immobilier, for the Charenton-Bercy redevelopment project in the Greater Paris area, and the acquisition of the Nicholsons Shopping Center in Maidenhead, United Kingdom.

Launched in June 2018, this pan-European value-added fund investing across all asset classes is a vehicle that offers co-investment opportunities to large institutional investors.

Tikehau Capital’s Head of Real Estate Frédéric Jariel said: “This investment is another step in the deployment of our value-added fund and confirms our interest in the hospitality sector as part of the dynamic expansion ofour Real Estate activity”. An operation carried out in collaboration with Le Groupe de l’Hôtellerie Le Groupe de l’Hôtellerie is a French based hotel management, investment and development specialist, which accompanies Tikehau Capital as a hospitality-operating partner.

Le Groupe de l’Hôtellerie’s CEO Gilles Douillard added: “We are excited to work closely with Tikehau Capital on this operation. The hospitality sector offers many opportunities for value-added development projects and we are pleased to share our expertise to support this project”.1Parisian Regional Tourism Committee: In the hotel industry, with 35.0 million guests in 2018, the number of arrivals was up by 3.6% compared to 2017

About Tikehau Capital

Tikehau Capital is an asset management and investment group with €22.4billion of assets under management and shareholders’ equity of €2.3 billion (as at 31 March 2019). The Group invests in various asset classes (private debt, real estate, private equity and liquid strategies), including through its asset management subsidiaries, on behalf of institutional and private investors. Controlled by its managers, alongside leading institutional partners, Tikehau Capital employs more than 440 staff (as at 31 March 2019) in its Paris, London, Brussels, Madrid, Milan, New York, Seoul,Singapore and Tokyo offices. Tikehau Capital is listed on the regulated market of Euronext Paris, Compartment A (ISIN code: FR0013230612; Ticker: TKO.FP)www.tikehaucapital.comPress contactsTikehau Capital: Jawad Khatib–+33 1 40 06 11 27 France -Image 7 : Grégoire Lucas & Florence Coupry –+33 1 53 70 74 70UK -Finsbury: Arnaud Salla & Charles O’Brien –+44 207 251 3801press@tikehaucapital.com

Shareholderand Investor Contact:

Tikehau Capital: Louis Igonet –+33 1 40 06 11 11shareholders@tikehaucapital.com

DISCLAIMER:

This document is not an offer of securities for sale or investment advisory services. This document contains general information only and is not intended to represent general or specific investment advice. Past performance is not a reliable indicator of future results and targets are not guaranteed.Certain statements and forecasted data are based on current expectations, current market and economic conditions, estimates, projections, opinions and beliefs of Tikehau Capital and/or its affiliates. Due to various risks and uncertainties, actual results may differ materially from those reflected or contemplated in such forward-looking statements or in any of the case studies or forecasts. All references to Tikehau Capital’s advisory activities in the US or with respect to US persons relates to Tikehau Capital North America.

Categories: News

Tags:

Nordstjernan divests its holding in Salcomp

Nordstjernan

Nordstjernan has entered an agreement to divest its holding in Salcomp, a world-leading manufacturer of chargers for mobile phones and other electronic products for the smart and connected world, to Lingyi iTech. Lingyi is a listed Chinese component manufacturer with sales of more than USD 3 billion in 2018.

Salcomp, founded in 1975, reported sales of EUR 531 million in 2018. Its customers comprise all major manufacturers of mobile phones and the company has production facilities in China, India and Brazil. Nordstjernan has been owner of Salcomp since 2007 and currently owns 55 percent of the capital and votes. The transaction is being conducted jointly with the Sixth Swedish National Pension Fund (AP6), which has owned 45 percent of the capital and votes in Salcomp.

The transaction is subject to the approval of the regulatory authorities in China and Taiwan.

“Nordstjernan has been a long-term owner of Salcomp, a world-leading company in a highly competitive global market. We have now found what we consider to be the right industrial home for Salcomp. The merger will provide the company with greater possibilities to offer its customers a broader product portfolio. I would also like to take this opportunity to extend my sincere thanks to the management and all the employees at Salcomp for our time together,” says Peter Hofvenstam, President and CEO of Nordstjernan.

Peter Hofvenstam
President and CEO
Nordstjernan AB

Questions will be answered by:

Peter Hofvenstam, CEO Nordstjernan
E-mail: peter.hofvenstam@nordstjernan.se

Stefan Stern, Head of Communications Nordstjernan
Telephone: +46 70 636 74 17
E-mail: stefan.stern@nordstjernan.se

Nordstjernan is a family-controlled investment company whose business concept is to be an active owner that creates long-term and positive value growth. More information about Nordstjernan can be found on www.nordstjernan.se.

Categories: News

Tags: